September 30, 2020

The Niche

Knoepfler lab stem cell blog

MSC clinical trial

6 min read

Advanced Cell Technology (ACT; $ACTC) has a new paper out on using human embryonic stem cells (hESC) to make MSCs with potentially powerful therapeutic potential. The paper, entitled Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties, was published in the journal Stem Cells and Development. What’s the scoop on this paper and this area of adult stem cell preclinical/clinical research? It’s an interesting, notable paper. At the same time there are some areas in the paper that could have been …Read More